 MIRAMAR, Fla., March 31, 2021 GLOBE NEWSWIRE -- Generex Biotechnology Corporation OTCQB: GNBT Generex or the Company, an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care including the development of its innovative Complete Vaccine to fight SARS-CoV-2, today announced that it will hold a shareholder conference call on Thursday May 6, 2021 at 9:00 AM ET. 